TrialAnnals of surgery2015

Impact of neoadjuvant chemotherapy in stage II-III triple negative breast cancer on eligibility for breast-conserving surgery and breast conservation rates: surgical results from CALGB 40603 (Alliance).

Mehra Golshan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.